International Business Machines Corporation NYSE: IBM, an industry pioneer with a long-standing presence in the technology sector, offers a contrasting picture to the rapid growth and instability often seen in newer tech companies.
Backed by a strong focus on product innovation and healthy AI traction across various sectors, IBM is expected to gain from the Software segment.
IBM's Consulting segment is expected to have recorded lower revenues in the first quarter of 2025, owing to soft demand in some end markets and macroeconomic headwinds.
IBM is trading at premium valuation metrics and investors could wait for a better entry point to cash in on its long-term fundamentals.
IBM's growth prospects are weak compared to peers like Microsoft and Oracle, with a forward P/E of 22x and expected revenue growth of just 3%. Despite IBM's strong competitive advantages and ecosystem, its valuation is high, and growth appears already priced in, making it unattractive at current levels. IBM's stock chart signals potential downside, with a long-term ominous outlook, justifying a sell rating unless protected by an options collar.
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Consumer products company Procter & Gamble extended its dividend growth streak to 69 years and pharmaceutical company Johnson & Johnson announced its 63rd year of dividend growth. Investors can expect double-digit boosts in the 2nd half of April from Ameriprise Financial and industrial company Parker-Hannifin, which will announce its 69th year of dividend growth.
Recently, Zacks.com users have been paying close attention to IBM (IBM). This makes it worthwhile to examine what the stock has in store.
IBM's transformation into a leader in cloud, consulting, and AI has driven strong returns, with the Hakkoda acquisition enhancing its data transformation services. Despite competition from giants like Amazon, Microsoft, and Alphabet, IBM's strategic focus on AI and cloud positions it well for future growth. IBM's financial health is robust, with increasing revenue, profitability, and a strong dividend yield, making it an attractive investment.
A single number underscores how quickly IBM (IBM -0.04%) is tapping into the artificial intelligence (AI) opportunity right now.
Besides Wall Street's top -and-bottom-line estimates for IBM (IBM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
IBM (IBM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With a better price performance and attractive valuation metrics, IBM is relatively better placed than MSFT at the moment.